Finance

Lists
KRRO:NASDAQ
Korro Bio Inc
9,91 $
0,00%
(0,00) 1D
30 սեպ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Mkt. cap
145,93 մլն
Avg. vol.
160,39 հզր
Volume
46,00
52-wk high
55,89 $
52-wk low
5,20 $
EPS
-10,00 $
Beta
3,09
Shares outstanding
14,73 մլն
No. of employees
57
Mkt. cap
145,93 մլն
Avg. vol.
160,39 հզր
Volume
46,00
52-wk high
55,89 $
52-wk low
5,20 $
EPS
-10,00 $
Beta
3,09
Shares outstanding
14,73 մլն
No. of employees
57
News stories
From web sources and news partners
About Korro Bio Inc
CEO-
Employees57
Founded2014
Headquarters-
Sector-
Websitekorrobio.com
Analyst ratings
Based on 9 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current 9,91 $
30,00 $ (+202,72%)
Average
19,00 $ (+91,73%)
Lowest
10,00 $ (+0,91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yigal Nochomovitz
Citi
Buy
Maintained
21,00 $
+111,9%
09/09/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
15,00 $
+51,4%
08/21/2026
Luca Issi
RBC Capital
Hold
Maintained
10,00 $
+0,9%
08/07/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
21,00 $
+111,9%
08/07/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
30,00 $
+202,7%
08/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
22,00 $
+122%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
18,00 $
+81,6%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
15,00 $
+51,4%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
23,00 $
+132,1%
05/08/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
22,00 $
+122%
03/13/2026
Ryan Deschner
Raymond James
Buy
Upgraded
23,00 $
+132,1%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,09 մլն
1,29 մլն
-
-
Cost of goods sold
11,26 մլն
8,60 մլն
11,53 մլն
11,63 մլն
Cost of revenue
11,26 մլն
8,60 մլն
11,53 մլն
11,63 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,06 մլն
8,58 մլն
8,91 մլն
8,48 մլն
Operating expense
9,06 մլն
8,58 մլն
8,91 մլն
8,48 մլն
Total operating expenses
20,33 մլն
17,18 մլն
20,44 մլն
20,11 մլն
Operating income
-19,24 մլն
-15,88 մլն
-20,44 մլն
-20,11 մլն
Other non operating income
1,18 մլն
990,00 հզր
-
-
EBT including unusual items
-18,06 մլն
-49,41 մլն
-19,53 մլն
-18,81 մլն
EBT excluding unusual items
-18,06 մլն
-14,89 մլն
-19,53 մլն
-18,81 մլն
Income tax expense
-
636,00 հզր
95,00 հզր
108,00 հզր
Effective tax rate
-
-1,29%
-0,49%
-0,57%
Other operating expenses
-
-
-
-
Net income
-18,06 մլն
-50,04 մլն
-19,62 մլն
-18,92 մլն
Net profit margin
-1 656,97%
-3 873,22%
-
-
Earnings per share
-1,92
-1,65
-1,69
-1,07
Interest and investment income
-
-
906,00 հզր
1,30 մլն
Interest expense
-
-
-
-
Net interest expenses
-
-
906,00 հզր
1,30 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-18,06 մլն
-15,23 մլն
-20,06 մլն
-19,74 մլն
Gain or loss from assets sale
-
-18,00 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps